Skip to content

Study of the inhibitory effect on salt absorption by low doses intake of supplements

Study of the inhibitory effect on salt absorption by low doses intake of supplements - Study of the inhibitory effect on salt absorption by low doses intake of supplements

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046641
Enrollment
30
Registered
2022-01-14
Start date
2022-02-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Ingest 3 tablets of the test food in the first test and 3 tablets of placebo in the second test, once a day for 4 days. Ingest the prescribed food during each intake period and the previous 3 days. In

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2. Healthy Japanese who are 20 years old or more and under 65 years old

Exclusion criteria

Exclusion criteria: 1. Persons who have chronic illness, receiving medication, have a serious disease history 2. Persons who have been diagnosed with hypertension by a doctor 3. Persons who are allergic to foods 4. Persons who regularly take large amounts of the test food 5. Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect the absorption or discharge of salt 6. Persons who have a drinking habit (more than 3 days a week, 1 go or more in terms of sake per drinking day) 7. Persons with a BMI of less than 18.5 or 30 or more 8. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 9. Persons who were judged as inappropriate for study participants by the principal investigator

Design outcomes

Primary

MeasureTime frame
Amount of urinary sodium

Secondary

MeasureTime frame
Amount of urinary potassium and urinary creatinine

Countries

Japan

Contacts

Public ContactTakamasa Masuda

Healthcare Systems Co., Ltd. Clinical Research Department

masudat@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026